Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Neurology ; 66(9): 1418-24, 2006 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-16682677

RESUMEN

BACKGROUND: The prevalence and characteristics of sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease (sCJD) are poorly understood. METHODS: Seven consecutive patients with definite sCJD underwent a systematic assessment of sleep-wake disturbances, including clinical history, video-polysomnography, and actigraphy. Extent and distribution of neurodegeneration was estimated by brain autopsy in six patients. Western blot analyses enabling classification and quantification of the protease-resistant isoform of the prion protein, PrPSc, in thalamus and occipital cortex was available in four patients. RESULTS: Sleep-wake symptoms were observed in all patients, and were prominent in four of them. All patients had severe sleep EEG abnormalities with loss of sleep spindles, very low sleep efficiency, and virtual absence of REM sleep. The correlation between different methods to assess sleep-wake functions (history, polysomnography, actigraphy, videography) was generally poor. Brain autopsy revealed prominent changes in cortical areas, but only mild changes in the thalamus. No mutation of the PRNP gene was found. CONCLUSIONS: This study demonstrates in sporadic Creutzfeldt-Jakob disease, first, the existence of sleep-wake disturbances similar to those reported in fatal familial insomnia in the absence of prominent and isolated thalamic neuronal loss, and second, the need of a multimodal approach for the unambiguous assessment of sleep-wake functions in these patients.


Asunto(s)
Síndrome de Creutzfeldt-Jakob/fisiopatología , Trastornos del Sueño del Ritmo Circadiano/fisiopatología , Anciano , Amiloide/análisis , Amiloide/genética , Encéfalo/patología , Síndrome de Creutzfeldt-Jakob/complicaciones , Síndrome de Creutzfeldt-Jakob/patología , Análisis Mutacional de ADN , Femenino , Humanos , Insomnio Familiar Fatal/patología , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Actividad Motora , Polisomnografía , Proteínas PrPSc/análisis , Proteínas Priónicas , Priones , Precursores de Proteínas/análisis , Precursores de Proteínas/genética , Método Simple Ciego , Trastornos del Sueño del Ritmo Circadiano/etiología , Sueño REM , Tálamo/patología , Grabación en Video , Muñeca
2.
Laryngorhinootologie ; 82(8): 573-7, 2003 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-12915990

RESUMEN

BACKGROUND: The changed mineral status is well known in different tumor types. This phenomenon has influenced the redox potential of patients suffering from solid cancers. A prospective trial was conducted to evaluate the specifics for untreated head and neck cancer patients. MATERIAL AND METHODS: We included 100 patients with advanced squamous cell carcinoma of the head and neck region before each kind of treatment. Following serum-concentrations were measured by atom absorption spectrometry: selenium, copper, zinc, and ferrum. Additionally we evaluated the activity of glutathion peroxidase and the concentration of malondialdehyde of the serum. RESULTS: 66 % of all patients have shown a decreased serum-concentration of selenium. These patients were additionally characterized by decreased activities of endogenous glutathionperoxiase. A third of all patients had decreased zinc and iron levels. Copper was found enhanced in 30 %. In trend the malondialdehyde was increasing due to decreasing selenium levels. CONCLUSIONS: Head neck cancer patients show the same characteristic trace element status as other solid tumors: decreased selenium, zinc and iron, increased copper. The therapeutic consequences of these observations are still unclear.


Asunto(s)
Carcinoma de Células Escamosas/sangre , Neoplasias de Oído, Nariz y Garganta/sangre , Oligoelementos/sangre , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/radioterapia , Terapia Combinada , Cobre/sangre , Femenino , Glutatión Peroxidasa/sangre , Humanos , Hierro/sangre , Masculino , Malondialdehído/sangre , Persona de Mediana Edad , Estadificación de Neoplasias , Neoplasias de Oído, Nariz y Garganta/tratamiento farmacológico , Neoplasias de Oído, Nariz y Garganta/patología , Neoplasias de Oído, Nariz y Garganta/radioterapia , Valores de Referencia , Selenio/sangre , Selenio/deficiencia , Zinc/sangre
3.
Artículo en Alemán | MEDLINE | ID: mdl-14707478

RESUMEN

BACKGROUND: Complementary/alternative medicine (CAM) is gaining increasing importance especially in the treatment of patients with breast carcinoma. The purpose of this analysis was to investigate the prevalence of CAM in patients with breast carcinoma, to statistically describe the preparations and therapies used, and to determine the reasons for their use, the source of information and the individual perception. PATIENTS AND METHODS: The statements of 203 patients with breast carcinoma who underwent radiotherapy were analyzed. The median age was 54 years (range 38-77 years). All patients underwent surgery as first therapy. 36 patients received a second-line radiotherapy because of metastases (27 patients) or local recurrence (9 patients). RESULTS: 159 patients (78%) stated to carry out an additional treatment. 31 out of the 36 patients with metastases or local recurrence used CAM. Vitamin preparations (67%), mistletoe therapy (59%), and mineral preparations (33%) were used most frequently. 70% of the patients used a combination of two or more preparations/therapies. The most cited reason for using CAM was the aim of increasing quality of life (28%) and improving the immune system (27%). 72% stated an improvement of their individual perception. The main source of information was the general practitioner or the gynecologist. CONCLUSION: The radiotherapist has to take these complementary/alternative therapies into consideration; their importance should be evaluated in further studies.


Asunto(s)
Neoplasias de la Mama/terapia , Carcinoma/terapia , Terapias Complementarias/estadística & datos numéricos , Recurrencia Local de Neoplasia/terapia , Adulto , Anciano , Neoplasias de la Mama/patología , Carcinoma/secundario , Terapias Complementarias/métodos , Femenino , Conocimientos, Actitudes y Práctica en Salud , Humanos , Persona de Mediana Edad , Radioterapia Adyuvante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA